Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre … SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... The lancet oncology 19 (3), 295-309, 2018 | 558 | 2018 |
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a … SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... Lancet oncology, 2019 | 386 | 2019 |
The effect of waiting for radiotherapy for grade III/IV gliomas V Do, V Gebski, MB Barton Radiotherapy and Oncology 57 (2), 131-136, 2000 | 177 | 2000 |
Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? M Lock, E Chow, GR Pond, V Do, C Danjoux, R Dinniwell, J Lea, A Bezjak Clinical Oncology 16 (5), 332-338, 2004 | 48 | 2004 |
Maintaining bone health in patients with prostate cancer DJ Holmes‐Walker, H Woo, H Gurney, VT Do, DR Chipps Medical journal of Australia 184 (4), 176-179, 2006 | 42 | 2006 |
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial CCB Post, SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... International Journal of Radiation Oncology Biology physics, 2020 | 34* | 2020 |
Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy? AH Brand, V Do, A Stenlake International Journal of Gynecologic Cancer 22 (5), 2012 | 33 | 2012 |
Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma R Choo, V Do, S Herschorn, G DeBoer, C Danjoux, G Morton, CH Cheng, ... International Journal of Radiation Oncology* Biology* Physics 53 (2), 290-296, 2002 | 33 | 2002 |
Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose–volume histogram parameter reproducibility and anatomic position stability E Flower, V Do, J Sykes, C Dempsey, L Holloway, K Summerhayes, ... Brachytherapy 16 (2), 387-392, 2017 | 29 | 2017 |
The role of serial free/total prostate‐specific antigen ratios in a watchful observation protocol for men with localized prostate cancer V Do, R Choo, G De Boer, L Klotz, C Danjoux, G Morton, E Szumacher, ... BJU international 89 (7), 703-709, 2002 | 22 | 2002 |
Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma V Do, R Choo, G Deboer, S Herschorn, C Danjoux, CH Chen, I Barak BJU international 90 (1), 62-67, 2002 | 21 | 2002 |
Uterine papillary serous carcinoma: patterns of failure and survival W Wang, V Do, R Hogg, G Wain, A Brand, C Bull, A Stenlake, V Gebski Australian and New Zealand Journal of Obstetrics and Gynaecology 49 (4), 419-425, 2009 | 16 | 2009 |
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer. R Choo, V Do, L Sugar, L Klotz, E Bahk, E Hong, C Danjoux, G Morton, ... The Canadian Journal of Urology 11 (1), 2118-2124, 2004 | 14 | 2004 |
A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial … P Schofield, K Gough, M Pascoe, R Bergin, K White, L Mileshkin, ... Gynecologic Oncology, 2020 | 13 | 2020 |
Non–prostate-specific membrane antigen-avid metastatic lung nodule from primary prostatic adenocarcinoma D Shetty, H Loh, C Bui, R Mansberg, A Hadjashrafi, V Do Clinical Nuclear Medicine 41 (10), 776-778, 2016 | 13 | 2016 |
Estimation of an optimal chemotherapy utilisation rate for cancer: setting an evidence-based benchmark for quality cancer care SA Jacob, WL Ng, V Do Clinical Oncology 27 (2), 77-82, 2015 | 13 | 2015 |
A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial … IJ P.Schofield,K.Gough, M.Pascoe, R.Bergin, K.White, L.Mileshkin, D.Bernshaw ... | 13* | |
Radiation therapy techniques and treatment-related toxicity in the PORTEC-3 trial: Comparison of 3-dimensional conformal radiation therapy versus intensity-modulated radiation … BG Wortman, CCB Post, ME Powell, P Khaw, A Fyles, R D'Amico, ... International Journal of Radiation Oncology* Biology* Physics 112 (2), 390-399, 2022 | 11 | 2022 |
Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial MG Jameson, J McNamara, M Bailey, PE Metcalfe, LC Holloway, K Foo, ... Journal of Medical Imaging and Radiation Oncology 60 (4), 554-559, 2016 | 9 | 2016 |
Postoperative concurrent chronomodulated 5-fluorouracil/leucovorin infusion and pelvic radiotherapy for squamous cell carcinoma of the ovary arising from mature cystic teratoma VT Do, GM Thomas, GA Bjarnason International Journal of Gynecologic Cancer 11 (5), 2001 | 9 | 2001 |